News
Important Only
Stocks
Verizon Shares Jump on Strong Subscriber Growth and Buyback. Is It Too Late to Buy the Stock?
Key PointsVerizon turned in its best quarterly net subscriber addition numbers in more than five years.It also put in place a large stock buyback program and remains committed to its dividend. The stock is still attractively priced even after its recent gains. 10 stocks we like better than Verizon ...The Motley Fool
Tue, Feb 3
Other
Pfizer beats fourth quarter profit estimates on robust drug demand
Feb 3(Reuters) - Pfizer PFE.N on Tuesday reported fourth-quarter profit above Wall Street estimates, boosted by sustained demand for older drugs such as blood thinner Eliquis and heart disease drug Vyndaqel. On an adjusted basis, the company reported a profit of 66 cents per share, compared to analy...Reuters
Tue, Feb 3
Stocks
DaVita rises on upbeat annual profit forecast
Dialysis firm DaVita's DVA.N shares rise 10.6% to $121.05 premarket after co forecasts annual profit above estimatesCo expects 2026 adj. EPS to be between $13.60 and $15 vs analysts' average estimate of $12.65 - LSEG dataDVA attributes upbeat estimate to steady demand for its kidney dialysis...Reuters
Tue, Feb 3
Other
WTW beats profit estimates on strength in risk and brokerage unit
Feb 3 (Reuters) - Insurance broker WTW WTW.O beat Wall Street estimates for fourth-quarter profit on Tuesday, driven by a strong performance in its risk and brokerage business.Rising financial risks and natural disasters have prompted businesses to spend more on insurance, lifting the commissions of...Reuters
Tue, Feb 3
Economic Indicator
Brazil central bank signals rate-cut cycle but vows to keep policy tight
By Marcela AyresBRASILIA, Feb 3 (Reuters) - Brazil's central bank signaled on Tuesday it will begin cutting interest rates in March, but stressed borrowing costs must remain restrictive and that the size and duration of the easing cycle will be set over time, in line with incoming data.In minute...Reuters
Tue, Feb 3
Other
Pfizer's experimental drug shows up to 12.3% weight loss in mid-stage trial
Feb 3 (Reuters) - Pfizer PFE.N said on Tuesday its experimental obesity drug, which it acquired through the Metsera deal, showed up to 12.3% weight loss in patients without diabetes in a mid-stage trial.Reuters
Tue, Feb 3
Cryptocurrencies
Ripple leads UAE tokenization project to move more than AED 1 billion of diamonds on-chain
A UAE-based project backed by Ripple’s tokenization partners has moved tokenized polished diamonds worth more than AED 1 billion on the XRP Ledger. Auction house Billiton Diamond and UK-based tokenization service provider Ctrl Alt announced a partnership to tokenize about $280 million in diamonds, according to a press statement released on Tuesday. The assets are […]Cryptopolitan
Tue, Feb 3
Stocks
Merck falls on downbeat 2026 profit and sales forecasts
Shares of drugmaker Merck MRK.N fall 2% to $113.11 premarket Co says 2026 revenue will be $65.5 bln–$67 bln, with the high end below analysts’ $67.6 bln forecast and profit also came in below Wall Street estimatesCo reports Q4 adj.profit of $2.04/shr vs analysts' average estimate of $2.01/shr -...Reuters
Tue, Feb 3
Other
Convenience store operator Arko warns of likely Q4 loss
OverviewConvenience store operator's preliminary Q4 net income ranges from a net loss of $1.8 million and net income of $0.4 millionPreliminary Q4 adjusted EBITDA expected between $63.1 mln and $66.1 mlnArko Petroleum launches IPO roadshow, significant for company's businessOutlookCompany pl...Reuters
Tue, Feb 3
Stocks
MORNING BID AMERICAS-Deals and delays
By Mike Dolan Feb 3 - What matters in U.S. and global markets todayBy Mike Dolan, Editor-At-Large, Finance and Markets Amid the dramatic twists and turns of the year so far, U.S. manufacturing seems to have rebounded sharply - with ISM survey showing factory activity expanding in January for...Reuters
Tue, Feb 3
Commodities
Siemens Energy CEO: wind spin-off idea valid, but turnaround comes first
By Christoph Steitz and Laila Kearney FRANKFURT/NEW YORK, Feb 3 (Reuters) - Siemens Energy's ENR1n.DE CEO said on Tuesday it was reasonable for activist investor Ananym Capital to push for a spin-off of the firm's loss-making wind turbine division, but added the unit must first be stabili...Reuters
Tue, Feb 3
Stocks
Why I've Decided Not to Leave My Sons a Bundle of Money
Key PointsThe money you spend your life saving may best be used to create memories.It's easy to believe people feel one way, when the reality is the polar opposite. Enjoying your senior years involves giving yourself permission. The $23,760 Social Security bonus most retirees completely overlook › S...The Motley Fool
Tue, Feb 3
Economic Indicator
India: US cuts tariffs on India – DBS
DBS Group Research report, authored by Radhika Rao, notes that the US and India have agreed on a trade deal, reducing tariffs on Indian goods from 25% to 18%. This agreement is contingent on India's continued reduction of oil purchases from Russia.Fxstreet
Tue, Feb 3
Other
KCC Estimates Privately Insured Loss From Winter Storm Fern Will Be $6.7 Billion
Feb 3 (Reuters) - Karen Clark & Company (KCC):KCC ESTIMATES PRIVATELY INSURED LOSS FROM WINTER STORM FERN WILL BE $6.7 BILLIONKCC SAYS ESTIMATE INCLUDES PRIVATELY INSURED DAMAGE TO RESIDENTIAL, COMMERCIAL, AND INDUSTRIAL PROPERTIES FROM FREEZE, SNOW/ICE, AND WINDReuters
Tue, Feb 3
Cryptocurrencies
Vitalik Buterin Argues Merging DAOs and Prediction Markets Is Good for Creators as SUBBD Token Soars
Ethereum co-founder Vitalik Buterin is at it again. This time, he’s pivoting the crypto conversation toward the intersection of decentralized autonomous organizations (DAOs) and prediction markets, a concept he calls ‘info finance.’ In recent commentary on the evolution of on-chain...Bitcoinist
Tue, Feb 3
Forex
Graphic Packaging Q4 revenue beats expectations
OverviewSustainable packaging firm's Q4 revenue rose, beating analyst expectationsAdjusted EPS for Q4 missed analyst expectationsCompany initiated a comprehensive review of operations and portfolioOutlookGraphic Packaging expects 2026 Net Sales of $8.4 bln to $8.6 blnCompany anticipates 2026 Adj...Reuters
Tue, Feb 3
Other
Merck Q4 revenue misses estimates on lower Gardasil demand
OverviewPharmaceutical firm's Q4 revenue grew 5% but missed analyst expectationsAdjusted EPS for Q4 beat analyst expectationsCompany highlighted progress in pipeline and acquisitionsOutlookMerck anticipates 2026 sales between $65.5 bln and $67.0 blnCompany expects 2026 non-GAAP EPS between $5.00...Reuters
Tue, Feb 3
Stocks
Evercore spots buying opportunity in West Pharma amid strong Oral Wegovy prescription data
Brokerage Evercore ISI says West Pharma's shares WST.N are down about 15% since Novo Nordisk launched oral Wegovy on Jan 5, because investors are worried oral GLP‑1 pills could reduce demand for injectable GLP‑1 drugs, which matter for WST's growthEvercore argues the recent selloff creates a...Reuters
Tue, Feb 3
Other
Eaton Q4 adjusted EPS beats, revenue slightly misses estimates
OverviewPower management firm's Q4 adjusted EPS beat analyst expectationsQ4 revenue slightly missed analyst expectationsCompany reported strong organic growth driven by Electrical and Aerospace segmentsOutlookEaton expects 2026 earnings per share between $11.57 and $12.07Company anticipates 2026...Reuters
Tue, Feb 3
